254 related articles for article (PubMed ID: 2864639)
1. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
Lemmer B; Winkler H; Ohm T; Fink M
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
[TBL] [Abstract][Full Text] [Related]
2. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
[TBL] [Abstract][Full Text] [Related]
3. Circadian phase dependency of the effects of different beta-receptor blocking drugs on motor activity of rats. Importance of drug lipophilicity.
Lemmer B; Neumann G
Arzneimittelforschung; 1987 Mar; 37(3):321-5. PubMed ID: 2885007
[TBL] [Abstract][Full Text] [Related]
4. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
[TBL] [Abstract][Full Text] [Related]
5. Stereospecific and circadian-phase-dependent kinetic behavior of d,l-, l-, and d-propranolol in plasma, heart, and brain of light--dark-synchronized rats.
Lemmer B; Bathe K
J Cardiovasc Pharmacol; 1982; 4(4):635-44. PubMed ID: 6181339
[TBL] [Abstract][Full Text] [Related]
6. Formation of the N-nitroso derivatives of six beta-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes.
Robbiano L; Martelli A; Allavena A; Mazzei M; Gazzaniga GM; Brambilla G
Cancer Res; 1991 May; 51(9):2273-9. PubMed ID: 1673086
[TBL] [Abstract][Full Text] [Related]
7. [Comparative pharmacokinetics of beta-blockers].
Kiechel JR; Meier J
Nouv Presse Med; 1978 Sep; 7(31):2685-7. PubMed ID: 30943
[No Abstract] [Full Text] [Related]
8. Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.
Feely J
Clin Pharmacokinet; 1983; 8(1):1-16. PubMed ID: 6132696
[No Abstract] [Full Text] [Related]
9. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
[TBL] [Abstract][Full Text] [Related]
10. Beta-blocker brain concentrations in man.
Cruickshank JM; Neil-Dwyer G
Eur J Clin Pharmacol; 1985; 28 Suppl():21-3. PubMed ID: 2865144
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.
Warrington SJ; Holt D; Johnston A; Fitzsimons TJ
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):37S-44S. PubMed ID: 6146339
[TBL] [Abstract][Full Text] [Related]
12. Elimination of beta-blockers in sewage treatment plants.
Maurer M; Escher BI; Richle P; Schaffner C; Alder AC
Water Res; 2007 Apr; 41(7):1614-22. PubMed ID: 17303212
[TBL] [Abstract][Full Text] [Related]
13. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
Kirch W; Spahn H; Köhler H; Ohnhaus EE; Mutschler E
Klin Wochenschr; 1982 Nov; 60(22):1401-7. PubMed ID: 7176462
[TBL] [Abstract][Full Text] [Related]
14. Effects of metoprolol, alone and in combination with lidocaine, on ventricular fibrillation threshold: comparison with atenolol, propranolol, and pindolol.
Coram WM; Olson RW; Beil ME; Cabot CF; Weiss GB
J Cardiovasc Pharmacol; 1987 May; 9(5):611-21. PubMed ID: 2439844
[TBL] [Abstract][Full Text] [Related]
15. The effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol.
Houtzagers JJ; Streurman O; Regårdh CG
Br J Clin Pharmacol; 1982 Jul; 14(1):67-72. PubMed ID: 6125199
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, central nervous system uptake, and lipid solubility of propranolol, acebutolol, and sotalol.
Arendt RM; Greenblatt DJ; deJong RH; Bonin JD; Abernethy DR
Cardiology; 1984; 71(6):307-14. PubMed ID: 6151871
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.
Rigby JW; Scott AK; Hawksworth GM; Petrie JC
Br J Clin Pharmacol; 1985 Oct; 20(4):327-31. PubMed ID: 2866783
[TBL] [Abstract][Full Text] [Related]
18. Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol.
Ros FE; Innemee HC; van Zwieten PA
Doc Ophthalmol; 1980 Apr; 48(2):291-301. PubMed ID: 6105048
[TBL] [Abstract][Full Text] [Related]
19. Brain levels and acute antihypertensive activity of beta-blockers.
van Zwieten PA; Timmermans PB
Eur J Clin Pharmacol; 1985; 28 Suppl():13-9. PubMed ID: 2865143
[TBL] [Abstract][Full Text] [Related]
20. Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol.
Lennard MS; Tucker GT; Silas JH; Woods HF
Xenobiotica; 1986 May; 16(5):435-47. PubMed ID: 2874665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
